Flazacor 30 Mg Tablets

Flazacor 30 Mg Tablets

Description:

Flazacor 30 mg tablets are a prescription oral corticosteroid medication containing deflazacort, used for its potent anti-inflammatory and immunosuppressive effects. It is indicated in a wide range of inflammatory, allergic, autoimmune, and endocrine disorders where systemic corticosteroid therapy is required. Flazacor 30 mg is manufactured by Sedico and is intended for use under strict medical supervision to control symptoms such as inflammation, swelling, pain, and immune overactivity in various organ systems.

Indications:

• Endocrine disorders requiring systemic corticosteroids (e.g., adrenal insufficiency and other conditions as determined by the physician).
• Rheumatic disorders such as rheumatoid arthritis, osteoarthritis with inflammatory component, ankylosing spondylitis, and other inflammatory joint diseases.
• Collagen diseases (autoimmune connective tissue disorders) where corticosteroids are indicated.
• Dermatologic diseases including severe inflammatory and allergic skin conditions responsive to systemic corticosteroids.
• Allergic diseases such as severe or refractory allergic reactions and hypersensitivity conditions where systemic steroids are required.
• Respiratory diseases including asthma exacerbations and other steroid-responsive inflammatory lung conditions as prescribed by a doctor.
• Ophthalmic disorders involving severe inflammatory or allergic eye conditions requiring systemic corticosteroid therapy.
• Hematologic disorders such as certain steroid-responsive anemias and blood dyscrasias as indicated by a specialist.
• Neoplastic diseases where corticosteroids are used as part of palliative or combination therapy (e.g., certain hematologic malignancies) as directed by an oncologist.
• Renal diseases including steroid-responsive nephrotic syndrome and other inflammatory kidney conditions.
• Neurologic diseases where systemic corticosteroids are indicated (e.g., certain demyelinating or inflammatory neurologic disorders) under specialist supervision.

Active Ingredients / Key Components:

• Deflazacort – 30 mg per tablet
• Excipients: Other inactive ingredients are present to form the tablet core and coating; detailed excipient list and concentrations , please check the product leaflet or the manufacturer’s official website. Please refer to the official package leaflet for full composition.

Dosage & Administration / How to Use:

• Flazacor 30 mg tablets must be used exactly as prescribed by your physician. Do not change the dose or stop treatment abruptly without medical advice.
• Typical adult dosing: The dose and duration vary widely depending on the disease being treated, its severity, and patient response. Your doctor will determine the appropriate starting dose and any subsequent adjustments. Information on specific standard dosing regimens is not available in the provided data and must be taken from the prescribing physician or official leaflet.
• Route of administration: Oral. Swallow the tablet whole with a sufficient amount of water. Do not crush or chew unless your doctor or pharmacist advises otherwise.
• With or without food: Deflazacort may be taken with or after food to help reduce potential gastrointestinal discomfort, unless your doctor gives different instructions.
• Timing: Take at the same time each day, preferably in the morning, to mimic the body’s natural corticosteroid rhythm, unless your doctor instructs otherwise.
• Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one. Consult your doctor if multiple doses are missed.
• Tapering: Long-term corticosteroid therapy must usually be reduced gradually (tapered) rather than stopped suddenly, to avoid adrenal insufficiency. Always follow your doctor’s tapering schedule.
• Use in children and elderly: Dose adjustments may be required. Pediatric and geriatric dosing must be strictly determined by a physician. Do not use in children without medical supervision.

Clinical Benefits:

• Provides strong anti-inflammatory action, helping to reduce swelling, redness, and pain in a wide range of inflammatory conditions.
• Offers immunosuppressive effects, helping to control overactive immune responses in autoimmune and collagen diseases.
• Helps manage acute exacerbations of respiratory and allergic conditions, improving breathing and reducing severe allergic symptoms when indicated.
• Supports symptom control in endocrine, renal, hematologic, neurologic, and certain neoplastic diseases where systemic corticosteroids are part of standard therapy.

Warnings & Contraindications:

• Use only under medical supervision. Long-term or high-dose corticosteroid use can cause serious side effects and requires regular monitoring.
• Contraindications may include known hypersensitivity to deflazacort or any component of the product, and certain untreated systemic infections. Full contraindication list is not available in the provided information; consult the official leaflet and your doctor.
• Infections: Corticosteroids may mask signs of infection and increase susceptibility to bacterial, viral, fungal, or parasitic infections. Inform your doctor if you have any current or recurrent infections, or if you have been exposed to chickenpox or measles.
• Chronic conditions: Use with caution in patients with diabetes, hypertension, heart failure, peptic ulcer disease, osteoporosis, glaucoma, cataracts, psychiatric disorders, or liver or kidney impairment. Close monitoring is required.
• Vaccinations: Live vaccines are generally not recommended during systemic corticosteroid therapy. Inform your healthcare provider about all planned vaccinations.
• Pregnancy and breastfeeding: Use only if clearly needed and prescribed by a doctor after careful risk–benefit assessment. Discuss potential risks with your healthcare provider.
• Drug interactions: Deflazacort may interact with several medicines, including but not limited to: acetazolamide, aminoglutethimide, carbamazepine, carbenoxolone, insulin and other antidiabetic agents, ketoconazole, phenobarbital, phenytoin, primidone, rifabutin, and rifampicin. Inform your doctor and pharmacist about all medications, supplements, and herbal products you are taking.
• Adrenal suppression: Prolonged use can suppress the body’s own corticosteroid production. Abrupt withdrawal may cause adrenal insufficiency, fatigue, low blood pressure, and other serious symptoms.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as diabetes, hypertension, heart disease, liver disease, kidney disease, osteoporosis, glaucoma, psychiatric illness, or active/previous infections.
• Not intended to diagnose, treat, cure, or prevent any disease without a doctor’s prescription and supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects (especially with prolonged use) may include weight gain, increased appetite, fluid retention, swelling of the face or limbs, mood changes, insomnia, elevated blood pressure, increased blood sugar, and indigestion or stomach discomfort.
• Long-term use may increase the risk of osteoporosis, muscle weakness, skin thinning, easy bruising, delayed wound healing, cataracts, glaucoma, and increased susceptibility to infections.
• Serious side effects can include severe allergic reactions, severe abdominal pain or black/tarry stools (possible gastrointestinal bleeding), vision changes, severe mood or behavioral changes, signs of infection (fever, sore throat, persistent cough), or symptoms of adrenal insufficiency (extreme fatigue, dizziness, fainting). Seek immediate medical attention if any serious or unusual symptoms occur.
• Not all possible side effects are listed here. For a complete list, consult the official patient information leaflet and your healthcare provider.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Do not store above the temperature specified on the package (exact temperature range is not available in the provided information; refer to the official leaflet).

Specifications:

• Product type: Prescription medicine – oral corticosteroid.
• Form: Tablets.
• Strength: 30 mg deflazacort per tablet.
• Pack size: 10 tablets per pack (flazacor 30 mg 10 tabs).
• Intended users: Adults and children as prescribed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.